The Global Influenza Hospital Surveillance Network (GIHSN): A new platform to describe the epidemiology of severe influenza

Influenza and other Respiratory Viruses

Volumn 9, Issue 6, 2015, Pages 277-286

  Puig Barberà, Joan ^a   Tormos, Anita ^a   Trushakova, Svetlana ^b   Sominina, Anna ^c   Pisareva, Maria ^c   Ciblak, Meral A ^d   Badur, Selim ^d   Yu, Hongjie ^e   Cowling, Benjamin J ^f   Burtseva, Elena ^b  

^a Vaccine Research Fundación para el Fomento de la Investigación Sanitaria   (Spain)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c Research Institute of Influenza   (Russian Federation)

^d National Influenza Reference Laboratory Capa Istanbul   (Turkey)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hospital; Influenza epidemiology; Surveillance network

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAZIL; CHILD; CHINA; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLUENZA; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH PROBLEM; RUSSIAN FEDERATION; SEASONAL VARIATION; SPAIN; TURKEY (REPUBLIC);

EID: 84944056018     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12335     Document Type: Article

References (32)

1. Hayward AC, Fragaszy EB, Bermingham A et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014; 2:445-454.
2. Lee VJ, Chen MI, Yap J et al. Comparability of different methods for estimating influenza infection rates over a single epidemic wave. Am J Epidemiol 2011; 174:468-478.
3. Donaldson LJ, Rutter PD, Ellis BM et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009; 339:b5213.
4. World Health Organization. Seasonal influenza factsheet no. 211. March 2014. Available at http://www.who.int/mediacentre/factsheets/fs211/en/ (Accessed 14 August 2014).
5. Puig-Barberà J, Tormos A, Sominina A et al. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health 2014; 14:564.
6. World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012; 87:461-476.
7. Huang QS, Baker M, McArthur C et al. Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand. Western Pac Surveill Response J 2014; 5:23-30.
8. Mertz D, Kim H, Johnstone J et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013; 347:f5061.
9. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 1994; 16:351-373.
10. World Health Organization. Global Epidemiological Surveillance Standards for Influenza. January 2014. Available at http://www.who.int/influenza/resources/documents/WHO_Epidemiological_Influenza_Surveillance:Standards_2014.pdf?ua=1 (Accessed 29 October 2014).
11. Cheng AC, Holmes M, Irving LB et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS ONE 2013; 8:e68760.
12. Brammer L, Budd A, Cox N. Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses 2009; 3:51-58.
13. Pan American Health Organization. REVELAC-i. PAHO; Available at http://www.paho.org/revelac-i/ (Accessed 04 February 2015)
14. Rondy M, Launay O, Puig-Barberà J et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill 2015; 20:pii=21011.
15. Dwyer DE, INSIGHT Influenza Study Group. Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies. Vaccine 2011; 29(Suppl 2):B56-B62.
16. Hirve S, Krishnan A, Dawood FS et al. Incidence of influenza-associated hospitalization in rural communities in western and northern India, 2010-2012: a multi-site population-based study. J Infect 2015; 70:160-170.
17. Puig-Barberà J, Natividad-Sancho A, Launay O et al. 2012-2013 seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the Global Influenza Hospital Surveillance Network. PLoS ONE 2014; 9:e100497.
18. Rothman KJ, Greenland S, Lash TL. Case-control studies; in Rothman KJ, Greenland S, Lash TL (eds): Modern Epidemiology. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008; 111-127.
19. Silvennoinen H, Peltola V, Vainionpää R, Ruuskanen O, Heikkinen T. Admission diagnoses of children 0-16 years of age hospitalized with influenza. Eur J Clin Microbiol Infect Dis 2012; 31:225-231.
20. Hayden FG, de Jong MD. Human influenza: pathogenesis, clinical features, and management; in Webster RG, Monto AS, Braciale TJ, Lamb RA (eds): Textbook of Influenza. Chichester, West Sussex, UK: Wiley Blackwell, 2013; 374-391.
21. European Influenza Surveillance Network (EISN). Influenza case definitions. Clinical criteria. Influenza-like illness (ILI). European Centre for Disease Prevention and Control (ECDC) 2005-2012; Available at http://ecdc.europa.eu/en/activities/surveillance/EISN/surveillance/Pages/influenza_case_definitions.aspx (Accessed 04 February 2015).
22. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of socioeconomic position (part 2). J Epidemiol Community Health 2006; 60:95-101.
23. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965; 14:61-65.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560.
25. Sullivan SG, Tay EL, Kelly H. Variable definitions of the influenza season and their impact on vaccine effectiveness estimates. Vaccine 2013; 31:4280-4283.
26. Northridge ME. Public health methods-attributable risk as a link between causality and public health action. Am J Public Health 1995; 85:1202-1204.
27. Cattaneo MD. Efficient semiparametric estimation of multi-valued treatment effects under ignorability. J Econom 2010; 155:138-154.
28. Puig-Barberà J, García-de-Lomas J, Díez-Domingo J et al. Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain. PLoS ONE 2014; 9:e112294.
29. Ellis PD. The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and the Interpretation of Research Results. New York, NY: Cambridge University Press, 2010.
30. Reed C, Biggerstaff M, Finelli L et al. Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics. Emerg Infect Dis 2013; 19:85-91.
31. World Health Organization. Review of the 2012-2013 winter influenza season, northern hemisphere. Wkly Epidemiol Rec 2013; 88:225-232.
32. World Health Organization. Review of the 2013-2014 winter influenza season, northern hemisphere. Wkly Epidemiol Rec 2014; 89:245-256.